Survival Outcomes Among Patients With Gastric Adenocarcinoma Who Received Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery
Open Access
- 1 August 2019
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 154 (8) , 780-782
Abstract
Gastric cancer (GC) with peritoneal metastases is associated with a poor prognosis. Median overall survival (OS) is less than 1 year with systemic chemotherapy alone.1 Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery (CRS) has been used for various peritoneal surface malignant tumors, and there has been marked interest in its application to GC because a small randomized clinical trial demonstrated improved OS among patients who underwent CRS-HIPEC compared with CRS alone.2 Although widespread adoption of HIPEC for GC has been limited because of poor oncologic outcomes and high perioperative morbidity,3 interest in the use of intraperitoneal chemotherapy for patients with advanced GC persists.1 We assessed survial outcomes among patients with gastric adenocarcinoma who received CRS-HIPEC at academic centers across the United States.Keywords
This publication has 6 references indexed in Scilit:
- Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric AdenocarcinomaAnnals of Surgical Oncology, 2017
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancerWorld Journal of Gastroenterology, 2016
- A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S‐1 for treatment of gastric cancer with macroscopic peritoneal metastasisCancer, 2013
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical TrialAnnals of Surgical Oncology, 2011
- Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal ChemotherapyAnnals of Surgical Oncology, 2010
- Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancerJournal of Gastrointestinal Surgery, 2004